UBS ASSET MANAGEMENT AMERICAS INC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$289,942
+74.7%
28,068
+89.0%
0.00%
Q2 2023$165,9890.0%14,8470.0%0.00%
Q1 2023$165,989
-99.9%
14,847
+67.1%
0.00%
Q1 2022$220,486,000
-22.6%
8,8870.0%0.00%
Q4 2021$285,006,000
+19.2%
8,887
+33.7%
0.00%
Q3 2021$239,123,000
-49.5%
6,646
-38.1%
0.00%
Q2 2021$473,937,00010,7420.00%
Other shareholders
PULMONX CORP shareholders Q1 2023
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders